Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Boundary-Guided Mammographic Radiomics for Molecular Subtype Risk Stratification in Breast Cancer.

Created on 30 Oct 2026

Authors

Adnan Khalid, Muhammad Mursil, Carlos Lopez Pablo, Ramon Bosch Princep, Sebastian Leonardo Kohan, Josep Guma Padro, Domenec Puig, Hatem A Rashwan

Published in

IEEE journal of biomedical and health informatics. Volume PP. Oct 29, 2026. Epub Oct 29, 2026.

Abstract

This work proposes a multi-stage interpretable framework for mammography-based molecular subtype-oriented risk stratification in breast cancer, focusing on visible mass lesions with segmentable tumor boundaries. The framework integrates a Boundary-Enhanced module within an attention-based U-Net architecture to improve tumor boundary delineation. Morphological and radiomics descriptors capturing shape, margin-related geometry, intensity, and texture heterogeneity are then extracted from the segmented tumor region and used for machine-learning-based subtype-oriented classification. For this task, the best-performing CatBoost model achieved an ROC AUC of 94.6% on Dataset A and 93.7% on Dataset B, used as an external test cohort for downstream subtype classification. These findings suggest that boundary-guided mammographic radiomics may provide a non-invasive adjunct for pre-biopsy risk stratification and subtype-oriented clinical assessment. However, tissue-based pathological evaluation remains the reference standard for definitive molecular subtype determination.

PMID:
42955765
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement